The Effect of Midazolam Premedication on Copeptine Concentration in Blood

NCT03474939 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-04-19

No results posted yet for this study

Summary

The study aim is to assess whether premedication with midazolam prior to surgery affects copeptin concentration in blood.

Conditions

  • Preanesthetic Medication
  • Copeptin

Interventions

DRUG

Midazolam Oral Tablet

Midazolam Oral tablet

OTHER

Placebo Oral Tablet

Glucose 1000mg tablet night before surgery and 60 minutes before surgery

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-03
Primary Completion
2019-03-01
Completion
2019-03-01

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03474939 on ClinicalTrials.gov